drugset / Trial / NCT07402213
Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This Phase III Trial is Meant to Evaluate the Efficacy, and Safety of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria.
Timeline
- Start
- 2026-03-31
- Primary completion
- 2027-06-30
- Completion
- 2028-04-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OZUREPRUBART | Monoclonal antibody | 300 mg | Subcutaneous |